SCHEMBL26401560

SCHEMBL26401560

COc1ccc(N(c2ccc(CO)cc2)c2ccccc2-c2ccc3c(c2)-c2cc(-c4ccccc4N(c4ccc(CO)cc4)c4ccc(CO)cc4)ccc2S32(=O)c3ccc(-c4ccccc4N(c4ccc(CO)cc4)c4ccc(OC)cc4)cc3-c3cc(-c4ccccc4N(c4ccc(OC)cc4)c4ccc(OC)cc4)ccc32)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LTB4R2 Q9NPC1 1/20 0.39
▸ ABL1 P00519 1/20 0.36
▸ ABCB1 P08183 1/20 0.36
▸ BCR P11274 1/20 0.36
▸ HDAC4 P56524 1/20 0.36
▸ HDAC2 Q92769 1/20 0.36
▸ HDAC8 Q9BY41 1/20 0.36
▸ LPAR1 Q92633 2/20 0.36
▸ RPS6KA2 Q15349 1/20 0.36
▸ FFAR1 O14842 1/20 0.35
▸ FFAR4 Q5NUL3 1/20 0.35
▸ KEAP1 Q14145 2/20 0.35
▸ NFE2L2 Q16236 2/20 0.35
▸ STAT3 P40763 1/20 0.35
▸ RAB9A P51151 1/20 0.34
▸ HSP90AA1 P07900 1/20 0.34
▸ GFER P55789 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ MEN1 O00255 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26401419 0.98 LTB4R2 (0.38) LTB4R2ABL1ABCB1BCRHDAC4
SCHEMBL22928311 0.91 ABL1 (0.40) LTB4R2ABL1ABCB1BCRHDAC4
SCHEMBL22928326 0.89 ABL1 (0.38) LTB4R2ABL1ABCB1BCRHDAC4
SCHEMBL22928716 0.89 ABL1 (0.38) LTB4R2ABL1ABCB1BCRHDAC4
SCHEMBL22928325 0.78 PTPRC (0.32) LTB4R2RAB9AMEN1KMT2A
SCHEMBL22928711 0.75 METAP2 (0.30) —
SCHEMBL1005483 0.73 ABL1 (0.51) ABL1ABCB1BCRHDAC4HDAC2
SCHEMBL30501493 0.73 ABL1 (0.47) LTB4R2ABL1ABCB1BCRHDAC4
SCHEMBL22928408 0.73 PTAFR (0.33) RAB9AMAPTMEN1KMT2AL3MBTL1
SCHEMBL13777888 0.72 LTA4H (0.47) LTB4R2RAB9AMAPTHPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11780831-B2 Compound, display panel and display apparatus Shanghai Tianma AM-OLED Co., Ltd. (CN) 2023-10-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11780831-B2 Compound, display panel and display apparatus C1S, DRD1, DRD3 LTB4R2 695/4885ABL1 422/4885ABCB1 3346/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback